{"id":3354,"date":"2024-04-29T11:13:15","date_gmt":"2024-04-29T08:13:15","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=3354"},"modified":"2024-04-29T11:13:16","modified_gmt":"2024-04-29T08:13:16","slug":"kedrion-turkiye-great-place-to-work-tarafindan-verilen-wellbeing-ozel-odulunun-sahibi-oldu","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=3354","title":{"rendered":"Kedrion T\u00fcrkiye Great Place to Work Taraf\u0131ndan Verilen Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u2019n\u00fcn Sahibi Oldu!"},"content":{"rendered":"\n<p><strong>Plazma kaynakl\u0131 \u00fcr\u00fcnlerle nadir ve \u00e7ok nadir hastal\u0131klar i\u00e7in tedavi \u00e7\u00f6z\u00fcmleri sunan Kedrion Biopharma\u2019n\u0131n yan kurulu\u015fu olan Kedrion T\u00fcrkiye, Great Place to Work Enstit\u00fcs\u00fc taraf\u0131ndan \u201cGreat Place to Work Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u201dn\u00fc almaya hak kazand\u0131. Kedrion, daha \u00f6nce ald\u0131\u011f\u0131 sertifikan\u0131n ard\u0131ndan ald\u0131\u011f\u0131 bu \u00f6zel \u00f6d\u00fclle birlikte ba\u015far\u0131l\u0131 kurum k\u00fclt\u00fcr\u00fc uygulamalar\u0131n\u0131 da tescillemi\u015f&nbsp;oldu.<\/strong><\/p>\n\n\n\n<p>Kedrion T\u00fcrkiye, kurum k\u00fclt\u00fcrlerini ve \u00e7al\u0131\u015fan deneyimini de\u011ferlendiren ba\u011f\u0131ms\u0131z ara\u015ft\u0131rma kurumu Great Place to Work Enstit\u00fcs\u00fc taraf\u0131ndan verilen Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u2019n\u00fcn sahibi oldu.&nbsp;<\/p>\n\n\n\n<p>\u00c7al\u0131\u015fanlar\u0131 i\u00e7in g\u00f6stermi\u015f oldu\u011fu \u00fcst\u00fcn \u00e7aba ve yenilik\u00e7i uygulamalarla daha \u00f6nce Great Place to Work\u2019\u00fcn \u201cT\u00fcrkiye\u2019nin En \u0130yi \u0130\u015fverenleri 2024\u201d listesine girmeyi ba\u015faran Kedrion T\u00fcrkiye, \u00e7al\u0131\u015fanlar\u0131n\u0131n sa\u011fl\u0131k ve refah\u0131n\u0131 \u00f6ncelikli tutan yakla\u015f\u0131mlar\u0131 sayesinde de Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u2019n\u00fc almaya hak kazand\u0131. \u015eirket de\u011ferlerinden \u00f6zeni ve insan\u0131 odak noktas\u0131na alan, \u00e7al\u0131\u015fanlar\u0131n\u0131n iyi olu\u015funu sa\u011flamak i\u00e7in yapm\u0131\u015f oldu\u011fu \u00e7al\u0131\u015fmalar\u0131n sonucu olan bu \u00f6d\u00fcl ile Kedrion\u2019un \u00e7al\u0131\u015fanlar\u0131na \u00f6zel wellbeing program\u0131yla hayata ge\u00e7irdi\u011fi d\u00fczenli egzersiz, temiz beslenme ve adil \u00e7al\u0131\u015fma saatleri gibi uygulamalar\u0131 \u00f6d\u00fcllendirilmi\u015f oldu.&nbsp;<\/p>\n\n\n\n<p>Great Place to Work Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u2019n\u00fcn kurum olarak kazan\u0131lmas\u0131ndan dolay\u0131 ya\u015fad\u0131\u011f\u0131 gururu dile getiren <strong>Kedrion T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Sema \u00d6zel Baydar,&nbsp;<\/strong>\u201cGreat Place to Work Enstit\u00fcs\u00fc taraf\u0131ndan daha \u00f6nce \u201cGreat Place to Work\u201d sertifikas\u0131n\u0131, ard\u0131ndan da \u201cGreat Place to Work Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u201dn\u00fc almaya hak kazand\u0131k. Bu \u00f6d\u00fcller, plazma kaynakl\u0131 hastal\u0131klar\u0131n tedavisinde \u00f6nc\u00fcl\u00fck etti\u011fimiz alanda, \u00e7al\u0131\u015fanlar\u0131m\u0131za g\u00f6sterdi\u011fimiz \u00f6zen, sa\u011fl\u0131k ve mutluluklar\u0131n\u0131 destekleme konusundaki sars\u0131lmaz taahh\u00fcd\u00fcm\u00fcz\u00fcn bir g\u00f6stergesi olarak b\u00fcy\u00fck \u00f6nem ta\u015f\u0131yor. Sa\u011fl\u0131k misyonumuzu yaln\u0131zca \u00fcr\u00fcnlerimizde de\u011fil \u00e7al\u0131\u015fan haklar\u0131nda da \u00f6nemsiyoruz. Ayr\u0131ca do\u011faya, gezegene ve d\u00fcnyaya katk\u0131 sa\u011fl\u0131yor, kendi b\u00fcy\u00fcd\u00fck\u00e7e \u00e7al\u0131\u015fanlar\u0131n\u0131 da her anlamda b\u00fcy\u00fctebilen bir \u015firket olma hedefini ta\u015f\u0131yoruz. T\u00fcm bunlar\u0131n sonucunda \u00f6nce Great Place to Work \u201cT\u00fcrkiye\u2019nin En \u0130yi \u0130\u015fverenleri 2024\u201d listesine girmemiz, \u015fimdi de \u201cWellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u201dn\u00fc kazanmam\u0131z bizleri gururland\u0131r\u0131rken, bu unvanlar\u0131 korumak ad\u0131na bundan sonra yapaca\u011f\u0131m\u0131z \u00e7al\u0131\u015fmalar i\u00e7in de g\u00fc\u00e7 ve enerji veriyor. Her bir \u00e7al\u0131\u015fan\u0131m\u0131z\u0131n bu ba\u015far\u0131ya katk\u0131s\u0131n\u0131 takdir etmekle birlikte hep birlikte daha fazla ba\u015far\u0131ya imza ataca\u011f\u0131m\u0131za olan inanc\u0131m\u0131zla, \u00e7al\u0131\u015fanlar\u0131m\u0131z\u0131n refah\u0131n\u0131 daha da art\u0131rma y\u00f6n\u00fcndeki \u00e7al\u0131\u015fmalar\u0131m\u0131za h\u0131z kesmeden devam edece\u011fiz\u201d dedi.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Plazma kaynakl\u0131 \u00fcr\u00fcnlerle nadir ve \u00e7ok nadir hastal\u0131klar i\u00e7in tedavi \u00e7\u00f6z\u00fcmleri sunan Kedrion Biopharma\u2019n\u0131n yan kurulu\u015fu olan Kedrion T\u00fcrkiye, Great Place to Work Enstit\u00fcs\u00fc taraf\u0131ndan \u201cGreat Place to Work Wellbeing \u00d6zel \u00d6d\u00fcl\u00fc\u201dn\u00fc almaya hak kazand\u0131. Kedrion, daha \u00f6nce ald\u0131\u011f\u0131 sertifikan\u0131n ard\u0131ndan ald\u0131\u011f\u0131 bu \u00f6zel \u00f6d\u00fclle birlikte ba\u015far\u0131l\u0131 kurum k\u00fclt\u00fcr\u00fc uygulamalar\u0131n\u0131 da tescillemi\u015f\u00a0oldu.<\/p>\n","protected":false},"author":1,"featured_media":3355,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,42],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3354"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3354"}],"version-history":[{"count":1,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3354\/revisions"}],"predecessor-version":[{"id":3356,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/3354\/revisions\/3356"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/3355"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}